1988
DOI: 10.1250/ast.9.255
|View full text |Cite
|
Sign up to set email alerts
|

Acoustic pulse generation in excised muscle by pulsed proton beam irradiation and the possibility of clinical application to radiation therapy.

Abstract: Acoustic pulse generationin excised muscle by pulsed proton beam irradiation and the possibility of clinical application to radiation therapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

1
14
0

Year Published

1995
1995
2021
2021

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 14 publications
(15 citation statements)
references
References 4 publications
1
14
0
Order By: Relevance
“…Sulak et al experimentally detected acoustic signals produced by proton beams in fluid media and successfully demonstrated a thermal expansion model for this phenomenon . Hayakawa et al detected acoustic pulse signals in animal tissues and humans, demonstrating the feasibility of determining dose distribution in proton therapy . A 3D dosimetric scanner based on ionizing radiation‐induced acoustic computed tomography (RACT) was theoretically designed to verify dose distribution and proton range in a water phantom .…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Sulak et al experimentally detected acoustic signals produced by proton beams in fluid media and successfully demonstrated a thermal expansion model for this phenomenon . Hayakawa et al detected acoustic pulse signals in animal tissues and humans, demonstrating the feasibility of determining dose distribution in proton therapy . A 3D dosimetric scanner based on ionizing radiation‐induced acoustic computed tomography (RACT) was theoretically designed to verify dose distribution and proton range in a water phantom .…”
Section: Introductionmentioning
confidence: 99%
“…15 Hayakawa et al detected acoustic pulse signals in animal tissues and humans, demonstrating the feasibility of determining dose distribution in proton therapy. [22][23][24] A 3D dosimetric scanner based on ionizing radiation-induced acoustic computed tomography (RACT) was theoretically designed to verify dose distribution and proton range in a water phantom. 25 A clinical ultrasound array was deployed to localize the proton Bragg peak from reconstructed thermoacoustic images in water and gelatin phantoms, which provided perfectly co-registered overlay of the Bragg peak onto a standard ultrasound image acquired by the same ultrasound array, and overcame the presence of acoustic heterogeneity and speed of sound errors.…”
Section: Introductionmentioning
confidence: 99%
“…[6][7][8][9][10][11][12][13][14][15][16][17][18][19][20][21] Based on the difference between their characteristic proton spills, the protoacoustic pressure amplitude generated by single-bunch synchrotron spills (<1 µs) is expected to be higher than those generated by either clinical cyclotrons, which typically deliver proton spills with ∼50 µs rise and fall times, or clinical synchrotrons, which typically deliver with ∼200 µs rise and fall times. 22 Given the short (<1 µs) spill times and high (up to 100 mA instantaneous 11 ) proton current capabilities, previous observations of the protoacoustic signal have employed linear accelerator, 6 synchrotron, [7][8][9][10][11][12][13][14][15][16][17] and tandem-accelerator 18 proton sources. Protoacoustic signals have also been observed using cyclotron-derived proton beams, 6,19 but these have used custom, modifiable beam lines originally built for research before they were applied to clinical therapy use, and the spill rise times were not reported.…”
Section: Introductionmentioning
confidence: 99%
“…Previous protoacoustic measurements have utilized proton sources at dedicated facilities. [6][7][8][9][10][11][12][13][14][15][16][17][18][19][20][21] Based on the difference between their characteristic proton spills, the protoacoustic pressure amplitude generated by single-bunch synchrotron spills (<1 µs) is expected to be higher than those generated by either clinical cyclotrons, which typically deliver proton spills with ∼50 µs rise and fall times, or clinical synchrotrons, which typically deliver with ∼200 µs rise and fall times. 22 Given the short (<1 µs) spill times and high (up to 100 mA instantaneous 11 ) proton current capabilities, previous observations of the protoacoustic signal have employed linear accelerator, 6 synchrotron, 7-17 and tandem-accelerator 18 proton sources.…”
Section: Introductionmentioning
confidence: 99%
“…Only in 1988 it was shown that proton beams interacting with water and soft tissue could be detected by using the iono-acoustic effect. [2] Seven years later, in 1995, the real clinical breakthrough took place when Hayakawa demonstrated the detection of acoustic waves in vivo during proton therapy treatment of a hepatic patient. [3] In those days, it was already recognized that for a successful clinical application it is essential to measure the dose distribution in 3-D.…”
Section: Introductionmentioning
confidence: 99%